First Time Loading...

Halozyme Therapeutics Inc
NASDAQ:HALO

Watchlist Manager
Halozyme Therapeutics Inc Logo
Halozyme Therapeutics Inc
NASDAQ:HALO
Watchlist
Price: 44.75 USD -1.41% Market Closed
Updated: May 18, 2024

Revenue Breakdown

Breakdown by Geography
Halozyme Therapeutics Inc

Total Revenue: 829.3m USD
100%
United States: 587.2m USD
70.8%
Switzerland: 149m USD
18%
Belgium: 58.4m USD
7%
All Other Foreign: 19.6m USD
2.4%
Japan: 15.1m USD
1.8%
Show More
Show Less

Breakdown by Segments
Halozyme Therapeutics Inc

Total Revenue: 829.3m USD
100%
Royalties: 447.9m USD
54%
Product Sales, Net: 300.9m USD
36.3%
Revenues Under Collaborative Agreements: 80.5m USD
9.7%
Sale Of Device Partnered Products: 54.6m USD
6.6%
Show More
Show Less

See Also

Discover More